Covid-19 pins geographic needles in Ambu's core business – CEO hopes for stabilization ahead
Ambu's sales of single-use endoscopes moves forward in certain markets but plummets in others, and the murky picture can be tracked along the lines of the coronavirus' geographic and chronological movement, says CEO Juan Jose Gonzalez, who is pleased about the consolidated outlook and markets stabilizing.
BY ULRICH QUISTGAARD, TRANSLATED BY L.N. BARNES & DANIEL FRANK CHRISTENSEN
Compared to last year, sales growth for single-use endoscopes seems to have reached a standstill at Ambu.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Ambu joins green climate initiative
For subscribers
Ambu's Q3 ended better than expected
For subscribers
